跳至主要内容
临床试验/CTRI/2019/09/021110
CTRI/2019/09/021110尚未招募2 期

Effects of a standardized extract from Bacopa monnieri on the treatment of attention deficit & hyperactivity disorder in children and adolescents (ADHD)

atural Remedies Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Children/ adolescent of both sexes between 6 years to 16 years old who exhibit mild to moderate ADHD with predominantly inattentive or combined presentation according to DSM V criteria.
  • 2.Inattentive subset and hyperactivity subset of not greater than 23 on SNAP IV scale.
  • 3. Voluntary assent to participate in the study from all whose are more then 7 years of age.
  • 4. Informed Consent signed by legal guardian/research participant when possible.
  • 5. Results of lab tests(chemistry, blood count and urine), physical examination and vital parameters with no clinically significant changes.

排除标准

  • 1. WISC-IV-SF, subjects whose score are less than 80.
  • 2.Research participants with known hypersensitivity to the other medication. History of alcohol or drug abuse by research participant.
  • 3. Where the immediate concern is around another primary psychiatric diagnosis other than ADHD.
  • 4. Diagnosis of psychiatric comorbidities, except for simple phobia, adjustment disorders, learning disorders, oppositional defiant disorder and sleep disorders.
  • 5. History of seizures(except for mild febrile seizures) within 2 years from the time of recruitment.
  • 6. Diagnosis of Tourette Syndrome and chronic tics.
  • 7. Research participants who are making use of drugs for the treatment of ADHD in last three months.
  • 8. Research participants who are making use of anticonvulsants, antidepressants and anti psychotics upto 6 weeks prior to study entry.
  • 9. Positive beta HCG test for girls who have attained menarchy.
  • 10. Patient at identified risk of suicide through clinical interview.
  • 11. Children/ adolescents with ADHD predominantly hyperactive/impulsive.
  • 12. Other conditions considered by the investigator as reasonable for the disqualification of the subject,s participation in the study.

研究者

发起方
atural Remedies Private Limited

相似试验